European Atherosclerosis Society

Focus on... EAS 2012 Milan

Counting down to Congress, we highlight speakers participating in EAS 2012. This week's speakers in the spotlight are Professors Mark Majesky and Ulf Landmesser. Photo: H. Shaffer

Activities

EAS organizes Educational Activities, such as Advanced Courses and Fellowships. We also participate in Initiatives to develop Guidelines and Consensus Position Papers. EAS 2011 Gothenburg. Photo: Hannah Shaffer

For members

Information and benefits for EAS members

EAS 2012, Milan, Italy, 25-28 May

Join world experts in the atherosclerosis field for the Society's 80th Congress. Early-bird registration until March 12. Scientific Programme now available.

Focus on... Activities For Members Congress

EAS membership 2012 entitles you to a range of benefits.

EAS 2012 MILAN

Welcome message from Congress Chair, Professor Alberico Catapano

>> Congress website & general info
>> Plenary sessions
>> Workshop sessions
>> Congress registration

UPDATES
>> Recent website updates

FOCUS ON...
As we count down to this year's Congress, each week we highlight speakers who will participate in EAS 2012. This week the speakers in the spotlight are Professor Mark Majesky and Professor Ulf Landmesser.
>> Read more...

COURSES
>> February 9-10, Paris, France
Advanced Course III: Clinical Excellence in Cardiovascular Prevention and Lipidology

GRANTS & AWARDS
>> EAS 2012: Travel Grants
>> Young Investigator Award
>> Anitschkow Prize

COMMENTARY
>> EAS Featured Commentaries
>> Atherosclerosis Journal Highlighted Articles

COLLABORATIONS
>> With other Societies
>> Joint sessions at Congress
>> Corporate Partnership

RESOURCES
>> EAS-heartwire newsfeed
>> EAS 2011 Congress presentations as webcasts
>> EAS 2011 Congress session reports

GUIDELINES
>> ESC-EAS Joint Guidelines on Management of Dyslipidemia
>> European Guidelines on Cardiovascular Disease Prevention in Clinical Practice

CONSENSUS PAPERS
>> Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease
>> Lipoprotein(a) as a cardiovascular risk factor: current status